Safety concerns regarding ephedrine-type alkaloid-containing dietary supplements

被引:12
作者
Miller, SC [1 ]
机构
[1] Wright State Univ, Wright Patterson AFB, OH 45433 USA
关键词
D O I
10.7205/MILMED.169.2.87
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The U.S. Air Force has adopted a policy "strongly discourag(ing) the use of... ephedra." However, the literature regarding this topic is limited and widely opinioned. In light of growing public and medical debate over the safety and efficacy of ephedrine-type alkaloid-containing dietary supplements, a review of the literature and assessment of the data were accomplished. Methods: Studies regarding Ma Huang, ephedra, ephedrine-type alkaloids, ephedrine, and dietary supplements were reviewed (from databases Medline, HealthSTAR, CINAHL, Cochrane Clinical Trials Database). Food and Drug Administration and Government Accounting Office documents (including reports and interagency communications) were reviewed. Results: Significant manufacturing quality control issues exist. Few studies support their efficacy or safety. Weight loss and athletic performance appear to be only modestly improved, for short durations, in the setting of large numbers of (some serious) adverse event reports. Studies examining over-the-counter use are minimal. Conclusions: The current U.S. Air Force policy strongly discouraging the use of ephedrine-type alkaloid-containing dietary supplements appears to be supported.
引用
收藏
页码:87 / 93
页数:7
相关论文
共 52 条
[1]   The neurosurgeon in sport: Awareness of the risks of heatstroke and dietary supplements [J].
Bailes, JE ;
Cantu, RC ;
Day, AL .
NEUROSURGERY, 2002, 51 (02) :283-286
[2]   Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of herbal remedies [J].
Barnes, J ;
Mills, SY ;
Abbot, NC ;
Willoughby, M ;
Ernst, E .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (05) :496-500
[3]  
Betz JM, 1997, J AOAC INT, V80, P303
[4]   Use of nonprescription weight loss products - Results from a multistate survey [J].
Blanck, HM ;
Khan, LK ;
Serdula, MK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (08) :930-935
[5]   Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial [J].
Boozer, CN ;
Daly, PA ;
Homel, P ;
Solomon, JL ;
Blanchard, D ;
Nasser, JA ;
Strauss, R ;
Meredith, T .
INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (05) :593-604
[6]   USE AND ABUSE OF APPETITE-SUPPRESSANT DRUGS IN THE TREATMENT OF OBESITY [J].
BRAY, GA .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (07) :707-713
[7]   A PHARMACODYNAMIC INTERACTION BETWEEN CAFFEINE AND PHENYLPROPANOLAMINE [J].
BROWN, NJ ;
RYDER, D ;
BRANCH, RA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 50 (04) :363-371
[8]   STROKE ASSOCIATED WITH EPHEDRINE USE [J].
BRUNO, A ;
NOLTE, KB ;
CHAPIN, J .
NEUROLOGY, 1993, 43 (07) :1313-1316
[9]   Antiobesity and cardiovascular toxic effects of Citrus aurantium extracts in the rat:: a preliminary report [J].
Calapai, G ;
Firenzuoli, F ;
Saitta, A ;
Squadrito, F ;
Arlotta, MR ;
Costantino, G ;
Inferrera, G .
FITOTERAPIA, 1999, 70 (06) :586-592
[10]  
CAPWELL RR, 1995, AM J PSYCHIAT, V152, P647